Clostridium difficile, colloquially known as "C Diff," is an increasing public health risk, particularly in hospital settings, but also as a foodborne pathogen.  Researchers from the United Kingdom, who compared historical strains of C Diff to the strain involved in a large outbreak at Stoke Mandeville Hospital in 2003, say that one of the reasons is that the bug is evolving, and becoming more dangerous. 

Clostridium difficile is a bacterium that causes diarrheal illness in human beings.  Actually, however, it is a bug that is naturally, and quite frequently, present in the gastrointestinal tracts of even healthy humans.  In fact, the bug is present in as many as 3% of adults and 66% of infants.  It typically becomes pathogenic (i.e. capable of causing illness) when the normal intestinal flora in the GI tract is altered, typically as a result of antimocribial treatment in a hospital setting. 

But C Diff is not dangerous because it causes only a couple days of diarrhea. A  2002 study showed that the incidence of patients with C. Diff in hospital settings who suffered life-threatening symptoms increased from 1.6% to 3.2%. Forty-four patients required a colectomy and 20 others died directly from C. difficile colitis.  The UK study concluded that the bacteria has become more virulent because it has acquired genes which enable it to survive better in the environment, spread more easily and make patients more severely ill.

Thus, for more reasons than just that C. Diff is causing more and more illnesses, the recent UK study finding that the bug is evolving is more than a little disturbing.  At the risk of stating the obvious, hospitals are where sick people go . . . people who can least afford to become infected, or succumb to illness from, a bacteria that is becoming more and more virulent. 

Print:
Email this postTweet this postLike this postShare this post on LinkedIn
Photo of Drew Falkenstein Drew Falkenstein

Drew Falkenstein joined Marler Clark in January, 2004 and has concentrated his practice in representing victims of foodborne illness. He has litigated nationwide against some of the biggest food corporations in the world, including Dole, Kellogg’s, and McDonald’s.  He has worked on landmark…

Drew Falkenstein joined Marler Clark in January, 2004 and has concentrated his practice in representing victims of foodborne illness. He has litigated nationwide against some of the biggest food corporations in the world, including Dole, Kellogg’s, and McDonald’s.  He has worked on landmark cases that have helped shape food safety policy, HACCP protocol, and consumer rights, such as the E. coli outbreak in fresh spinach in 2006 and the 2008 Peanut Corporation of America outbreak of Salmonella. A frequent speaker for the not-for-profit organization Outbreak, Inc, Mr. Falkenstein travels the country to address public and environmental health organizations as well as food safety meetings and annual educational conferences.  He speaks on the intersection of law and public health, and addresses companies on how to prevent food borne illness outbreaks.